206 related articles for article (PubMed ID: 27815113)
1. Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats.
El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
Toxicol Lett; 2017 Jan; 265():23-29. PubMed ID: 27815113
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model.
El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
Toxicology; 2016 Jun; 359-360():29-38. PubMed ID: 27345130
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin: characterization of induced myopathy in the rat.
Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
[TBL] [Abstract][Full Text] [Related]
4. Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
Dorajoo Rs; Pereira BP; Yu Z; Gopalakrishnakone P; Leong CC; Wee A; Lee E
Life Sci; 2008 Apr; 82(15-16):823-30. PubMed ID: 18509883
[TBL] [Abstract][Full Text] [Related]
5. Statin-induced necrotizing autoimmune myopathy: importance of early recognition.
Hussenbux A; Hofer M; Steuer A
Br J Hosp Med (Lond); 2017 Jun; 78(6):352-353. PubMed ID: 28614015
[No Abstract] [Full Text] [Related]
6. Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle.
Bouitbir J; Singh F; Charles AL; Schlagowski AI; Bonifacio A; Echaniz-Laguna A; Geny B; Krähenbühl S; Zoll J
Antioxid Redox Signal; 2016 Jan; 24(2):84-98. PubMed ID: 26414931
[TBL] [Abstract][Full Text] [Related]
7. The role of mitochondria in statin-induced myopathy.
Apostolopoulou M; Corsini A; Roden M
Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
[TBL] [Abstract][Full Text] [Related]
8. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
Nichols L; Pfeifer K; Mammen AL; Shahnoor N; Konersman CG
J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481
[TBL] [Abstract][Full Text] [Related]
9. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Ramakumari N; Indumathi B; Katkam SK; Kutala VK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
[TBL] [Abstract][Full Text] [Related]
10. Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.
Sidaway J; Wang Y; Marsden AM; Orton TC; Westwood FR; Azuma CT; Scott RC
Xenobiotica; 2009 Jan; 39(1):90-8. PubMed ID: 19219751
[TBL] [Abstract][Full Text] [Related]
11. Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats.
Khalil MS; Khamis N; Al-Drees A; Abdulghani HM
Histol Histopathol; 2015 Mar; 30(3):383-90. PubMed ID: 25366571
[TBL] [Abstract][Full Text] [Related]
12. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.
Kaleağasıoğlu F; Olcay E; Olgaç V
Knee Surg Sports Traumatol Arthrosc; 2017 Jun; 25(6):1884-1891. PubMed ID: 26275370
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats.
Chogtu B; Ommurugan B; Thomson SR; Kalthur SG
ScientificWorldJournal; 2020; 2020():4704825. PubMed ID: 32292293
[TBL] [Abstract][Full Text] [Related]
14. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin.
Camerino GM; De Bellis M; Conte E; Liantonio A; Musaraj K; Cannone M; Fonzino A; Giustino A; De Luca A; Romano R; Camerino C; Laghezza A; Loiodice F; Desaphy JF; Conte Camerino D; Pierno S
Toxicol Appl Pharmacol; 2016 Sep; 306():36-46. PubMed ID: 27377005
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated necrotising myopathy linked to statin use.
Kipfer S; Frigerio S; Hench J; Aussy A; Boyer O
Lancet; 2015 Oct; 386(10005):e26. PubMed ID: 26074381
[No Abstract] [Full Text] [Related]
16. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.
Schaefer WH; Lawrence JW; Loughlin AF; Stoffregen DA; Mixson LA; Dean DC; Raab CE; Yu NX; Lankas GR; Frederick CB
Toxicol Appl Pharmacol; 2004 Jan; 194(1):10-23. PubMed ID: 14728975
[TBL] [Abstract][Full Text] [Related]
17. The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients.
Nurkalem Z; Yildirimtürk Ö; Özcan KS; Kul Ş; Çanga Y; Satılmış S; Bozbeyoğlu E; Kaya C
Kardiol Pol; 2014; 72(3):275-9. PubMed ID: 24142756
[TBL] [Abstract][Full Text] [Related]
18. Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy.
Mo L; He J; Yue Q; Dong B; Huang X
J Clin Pharm Ther; 2015 Apr; 40(2):245-8. PubMed ID: 25512016
[TBL] [Abstract][Full Text] [Related]
19. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
Fung EC; Crook MA
Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
